AlphAIalphai — Financial news for AI agents
stocktitan.netAUG 282 min read$TLRY

Tilray Brands (TLRY) CEO’s 1.21M-share PSU award detailed

Tilray Brands (TLRY) reported that CEO Irwin D. Simon's 1.21M performance-based restricted stock units converted into shares on August 26, 2026. 642,450 shares were withheld for taxes at $4.88 per share. The Compensation Committee certified 96.4% of the performance target, leading to a 92.8% payout of the 2023 EBITDA PSU awards.

Original reporting
stocktitan.net
Published Aug 28, 2026, 12:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 2:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$TLRY
Neutral
medium confidence
Mentioned
$TLRY
Relevance
5/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$TLRYNeutralLow
01

Why it matters

The filing provides the first public detail of the vesting event, indicating a sizable share issuance and tax‑related sell‑off.

02

Market read

Insider vesting events can affect share supply and investor perception, offering modest trading relevance.

03

What to watch

Tax withholding reduces net shares retained, mitigating dilution impact.

Relevance 5/10Novelty 6/10Timing: August 26, 2026 vesting date

Background

Tilray Brands (TLRY) disclosed a Form 4 showing CEO Irwin D. Simon's performance‑based restricted stock units vesting.

Company-level read

Ticker impact

$TLRYNeutralMedium confidence
Context

Form 4 filing shows CEO Irwin D. Simon vested 1.21M PSU shares on Aug 26, 2026, with tax withholding of 642,450 shares.

Expected impact

Potential slight downward pressure due to share dilution from tax withholding.

Evidence & confidence

The vesting adds over 1.2M shares to float and 642k were sold for tax, which can modestly dilute existing shareholders.

Market effects

Sector

Limited; reflects executive compensation trends in cannabis sector.

Regional

U.S. cannabis market may note increased insider activity.

Global

Low; specific to Tilray shareholders.

Counterpoint

What could challenge this read

Vesting could be seen as confidence, supporting upside despite dilution.

Key entities

  • Executive
    Irwin D. Simon

    President and CEO of Tilray Brands

Read at source← All news

Related articles

AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min
AUG 23
$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

yahoo.com3 min
AUG 21
$CURLFHighAI 8/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

fool.com3 min
AUG 7
$TLRYMed

Tilray Brands (TLRY) Is Up 5.7% After Narrower Loss, ESOP Shelf Filing and M&A Signal

Tilray Brands reported Q4 sales of US$281.71 million and full-year sales of US$915.45 million for the year ended May 31, 2026, with a substantially smaller net loss than the prior year. The company also filed a US$47.69 million shelf registration for 11,355,231 common shares tied to its ESOP. Management said at-the-market equity proceeds may fund acquisitions, including deals like BrewDog.

simplywall.st7 min
JUL 30
$TLRYMed

Tilray Brands Q4 Earnings Call Highlights

Tilray Brands (NASDAQ: TLRY) reported fiscal 2026 results on its Q4 earnings call. Net loss narrowed to $105.2M ($1.09/share) from about $2.2B in fiscal 2025. Adjusted net income rose 87% to $12.2M. Cannabis and distribution revenue grew, BrewDog added beverage revenue, and Tilray guided adjusted EBITDA of $68M to $75M for fiscal 2027.

yahoo.com6 min